Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi | Paris | Healthcare | Pharmaceuticals | €115.25B | 14.3x | -0.51 | €91.91 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.9% Upside | Upgrade to Pro+ | |
EssilorLuxottica | Paris | Healthcare | Healthcare Equipment & Supplies | €105.69B | 45.5x | -12.99 | €231.80 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -3.2% Downside | Upgrade to Pro+ | |
Sartorius Stedim | Paris | Healthcare | Healthcare Equipment & Supplies | €17.56B | 107.9x | -1.65 | €179.80 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.2% Upside | Upgrade to Pro+ | |
Biomerieux | Paris | Healthcare | Healthcare Equipment & Supplies | €11.54B | 28x | 4.2 | €97.80 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22.4% Upside | Upgrade to Pro+ | |
Eurofins Scientific | Paris | Healthcare | Healthcare Providers & Services | €9.05B | 33.3x | -1.35 | €46.90 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22.9% Upside | Upgrade to Pro+ | |
Ipsen | Paris | Healthcare | Pharmaceuticals | €8.89B | 13.2x | 0.27 | €108.20 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.7% Upside | Upgrade to Pro+ | |
Virbac | Paris | Healthcare | Pharmaceuticals | €2.68B | 19x | 1 | €320.50 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.5% Upside | Upgrade to Pro+ | |
Ramsay Generale De Sante | Paris | Healthcare | Healthcare Providers & Services | €1.25B | -23.2x | 0.11 | €11.30 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vetoquinol | Paris | Healthcare | Pharmaceuticals | €920.57M | 19.6x | -0.98 | €77.80 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.7% Upside | Upgrade to Pro+ | |
Emeis | Paris | Healthcare | Healthcare Providers & Services | €918.38M | 0.3x | 0.01 | €5.70 | -2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Clariane SE | Paris | Healthcare | Healthcare Providers & Services | €651.36M | -0x | 0 | €1.86 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.3% Upside | Upgrade to Pro+ | |
Medincell | Paris | Healthcare | Pharmaceuticals | €502.63M | -19.6x | -0.69 | €17.28 | -4.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25.6% Upside | Upgrade to Pro+ | |
Abivax SA | Paris | Healthcare | Biotechnology & Medical Research | €490.22M | -2.5x | -1.61 | €7.74 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Boiron | Paris | Healthcare | Pharmaceuticals | €485.28M | 20.5x | -0.4 | €27.95 | 3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22.9% Upside | Upgrade to Pro+ | |
Euroapi | Paris | Healthcare | Pharmaceuticals | €391.34M | -1.3x | 0 | €4.08 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -27% Downside | Upgrade to Pro+ | |
Guerbet | Paris | Healthcare | Healthcare Equipment & Supplies | €324.05M | 9.9x | 0.06 | €25.70 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Valneva | Paris | Healthcare | Biotechnology & Medical Research | €294.70M | -33.7x | -0.43 | €1.81 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Eurobio Scientific | Paris | Healthcare | Biotechnology & Medical Research | €257.12M | 42.6x | -1.73 | €25.60 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17% Upside | Upgrade to Pro+ | |
LNA Sante SA | Paris | Healthcare | Healthcare Providers & Services | €245.92M | 10.3x | €24.05 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29.2% Upside | Upgrade to Pro+ | ||
Inventiva | Paris | Healthcare | Biotechnology & Medical Research | €212.47M | -1.2x | 0.23 | €2.44 | 2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sensorion SA | Paris | Healthcare | Biotechnology & Medical Research | €206.65M | -6.6x | -0.14 | €0.69 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Lumibird SA | Paris | Healthcare | Healthcare Equipment & Supplies | €201.07M | 30.5x | -0.98 | €9.14 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 31.2% Upside | Upgrade to Pro+ | |
Cellectis | Paris | Healthcare | Biotechnology & Medical Research | €191.18M | -2x | -0.06 | €1.91 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genfit | Paris | Healthcare | Biotechnology & Medical Research | €188.48M | 8.4x | 0.05 | €3.78 | -3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ose Pharma International SA | Paris | Healthcare | Biotechnology & Medical Research | €166.63M | 3.6x | 0.02 | €7.68 | -13% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 47.2% Upside | Upgrade to Pro+ | |
Amplitude Surgical SAS | Paris | Healthcare | Healthcare Equipment & Supplies | €160.22M | 104.4x | -1.08 | €3.34 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bastide Le Confort | Paris | Healthcare | Healthcare Providers & Services | €154.19M | -174.4x | -0.19 | €21.10 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 41.8% Upside | Upgrade to Pro+ | |
Nanobiotix | Paris | Healthcare | Biotechnology & Medical Research | €136.05M | -3.7x | -0.08 | €2.85 | -4.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Innate Pharma | Paris | Healthcare | Biotechnology & Medical Research | €111.55M | -3.3x | -0.07 | €1.38 | -3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Adocia | Paris | Healthcare | Biotechnology & Medical Research | €110.86M | -4.8x | -0.15 | €7.17 | -4.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -16% Downside | Upgrade to Pro+ |